Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis-Reference-Cited by-同舟云学术

Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis

Published:2022-07-01 Issue:7 Volume:158 Page:735
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Gordon Kenneth B.¹,Langley Richard G.²,Warren Richard B.³,Okubo Yukari⁴,Stein Gold Linda⁵,Merola Joseph F.⁶,Peterson Luke⁷,Wixted Krista⁷,Cross Nancy⁷,Deherder Delphine⁸,Thaçi Diamant⁹

Affiliation:

1. Department of Dermatology, Medical College of Wisconsin, Milwaukee

2. Division of Clinical Dermatology and Cutaneous Science, Dalhousie University, Halifax, Nova Scotia, Canada

3. Dermatology Centre, Salford Royal NHS Foundation Trust, NIHR Manchester Biomedical Research Centre, The University of Manchester, Manchester, United Kingdom

4. Department of Dermatology, Tokyo Medical University, Tokyo, Japan

5. Dermatology Clinical Research, Henry Ford Health System, Detroit, Michigan

6. Department of Dermatology, Harvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts

7. UCB Pharma, Raleigh, North Carolina

8. UCB Pharma, Braine-l’Alleud, Belgium

9. Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany

Publisher

American Medical Association (AMA)

Subject

Dermatology

Link

https://jamanetwork.com/journals/jamadermatology/articlepdf/2791835/jamadermatology_gordon_2022_oi_220019_1657583981.95879.pdf

Reference46 articles.

1. Quality of life in patients with psoriasis.;Bhosle;Health Qual Life Outcomes,2006

2. Treatment approaches to moderate to severe psoriasis.;Gisondi;Int J Mol Sci,2017

3. Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis Registry.;Strober;BMJ Open,2019

4. Psoriasis and comorbid diseases: epidemiology.;Takeshita;J Am Acad Dermatol,2017

5. Secukinumab in plaque psoriasis—results of two phase 3 trials.;Langley;N Engl J Med,2014

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovations in Psoriasis;Dermatologic Clinics;2024-09

2. The Impact of Psoriasis Treatments on the Risk of Skin Cancer: A Narrative Review;Advances in Therapy;2024-08-28

3. Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study – IL PSO (Italian Landscape Psoriasis);Journal of Dermatological Treatment;2024-08-20

4. Bimekizumab safety in moderate to severe plaque psoriasis: Rates of hepatic events and changes in liver parameters over 2 years in randomized phase 3/3b trials;Journal of the American Academy of Dermatology;2024-08

5. Biologics for Psoriasis;Dermatologic Clinics;2024-07